Calendar Year Performance 2014Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023
+ 8.3 %
+ 0.2 %
+ 3.4 %
- 0.4 %
- 11.7 %
+ 10.0 %
+ 11.9 %
- 1.4 %
- 9.7 %
+ 1.7 %
Net Asset Value
167.0 €
Asset Under Management
6 392 M €
Market
Global market
SFDR - Fund Classification
Article
8
Data as of: 30 Apr 2024.
Data as of: 7 May 2024.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
US data continues to reflect a degree of economic resilience, with inflation figures still high. However, the disinflation trend continues in Europe. In the light of this, the Fed and the ECB are sticking to their plan and will probably start cutting interest rates this summer. The Bank of Japan bucked the trend: it put an end to eight years of negative interest rates, even amid increasing signs of substantial pay rises. This backdrop of robust growth, persistent inflation and more accommodative central banks is keeping the risky asset rally alive. The S&P 500 is having its best start to a year since 2019. Although the rally has mainly been fuelled by the Magnificent Seven, it spread to more corners of the market at the end of the month when cyclical sectors rebounded as commodity prices climbed. Oil was up 5% to $87 a barrel (Brent), while gold set a new record of more than $2,200 an ounce. Equity markets seem to have accepted the optimistic scenario under which central banks lower interest rates and the economy slows moderately, meaning that valuations are high though supported by earnings growth. Credit also continued to perform well. European yields eased in March, while the growth differential between the United States and the Eurozone persists.
Performance commentary
The Fund was up in March, beating its reference indicator. Our stock picking paid off once again, especially in technology and healthcare despite sector rotation during the month. Our semiconductor companies maintained their upward trajectory and published more excellent results, strengthening our investment case based on a growing imbalance between supply and demand. Exposure to gold stocks was also profitable in March, as bullion prices hit new highs. Our credit exposure also continues to generate steady positive returns thanks to the attractive carry on this asset class. Our decision to reduce the portfolio’s modified duration to an almost neutral level limited the impact of yields rising over the month. However, our yen exposure did not pay dividends, despite the Bank of Japan’s decision to terminate its negative interest rate policy.
Outlook strategy
Over the next few months, we expect global growth to stabilise as the manufacturing cycle picks up. This scenario, of slow but firm economic growth and more accommodative monetary policies, should continue to favour risky assets. However, as financial markets have already priced it in, with indices at record levels, a selective approach and profit-taking are necessary. We remain optimistic about artificial intelligence and obesity treatments, while also strengthening positions in sectors that had been lagging and diversifying others, especially in industrials. Credit still has strong upside potential as a result of carry. At a sovereign debt level, our exposure to interest rate movements remains limited as, despite signs of central banks pivoting, solid inflation and economic data call for caution, especially at the long end of the yield curve. We are also optimistic for commodities, especially gold and copper, which should benefit from the manufacturing industry’s gradual rebound, with diversified investments in equities, bonds and currencies.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
The Fund is a common fund in contractual form (FCP) conforming to the UCITS Directive under French law.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.
Unsupported browserWe've noticed that your browser is no longer supported. To ensure optimal performance and security while using our website, we recommend updating your browser or other relevant software. Thank you for your understanding!
Market environment
US data continues to reflect a degree of economic resilience, with inflation figures still high. However, the disinflation trend continues in Europe. In the light of this, the Fed and the ECB are sticking to their plan and will probably start cutting interest rates this summer. The Bank of Japan bucked the trend: it put an end to eight years of negative interest rates, even amid increasing signs of substantial pay rises. This backdrop of robust growth, persistent inflation and more accommodative central banks is keeping the risky asset rally alive. The S&P 500 is having its best start to a year since 2019. Although the rally has mainly been fuelled by the Magnificent Seven, it spread to more corners of the market at the end of the month when cyclical sectors rebounded as commodity prices climbed. Oil was up 5% to $87 a barrel (Brent), while gold set a new record of more than $2,200 an ounce. Equity markets seem to have accepted the optimistic scenario under which central banks lower interest rates and the economy slows moderately, meaning that valuations are high though supported by earnings growth. Credit also continued to perform well. European yields eased in March, while the growth differential between the United States and the Eurozone persists.